Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,178,547
-
Share change
-
0
-
Total reported value
-
$89,091,117
-
Price per share
-
$4.42
-
Number of holders
-
46
Institutional Holders of KALOBIOS PHARMACEUTICALS INC - COM (KBIO) as of Q4 2013
As of 31 Dec 2013,
KALOBIOS PHARMACEUTICALS INC - COM (KBIO) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,178,547 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, FMR LLC, MPM ASSET MANAGEMENT LLC, JPMORGAN CHASE & CO, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, First Eagle Investment Management, LLC, Lehman Brothers Holdings Inc., WALL STREET ASSOCIATES, FRANKLIN RESOURCES INC, and PRINCIPAL FINANCIAL GROUP INC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.